Concepedia
Statistics
Publications
9
Citations
740
H-Index
Active since
2011
Affiliations
Duke University(Current)
Howard Hughes Medical Institute
University of Illinois Urbana-Champaign
Holly M. Alley is an author at Duke University specializing in oncology, medicine, and molecular oncology.
Publications per year
2011–2017
Systematic identification of signaling pathways with potential to confer anticancer drug resistance
Colin A. Martz, Kathleen Ottina, Katherine R. Singleton et al. · Science Signaling · 2014 · 199 citations
Medicine, Oncology, Pharmacology +17
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer
Suzanne E. Wardell, Matthew J. Ellis, Holly M. Alley et al. · Clinical Cancer Research · 2015 · 160 citations · Full text
Medicine, Oncology, Pharmacology +14
Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader
Suzanne E. Wardell, Erik R. Nelson, Christina Chao et al. · Endocrine Related Cancer · 2015 · 114 citations · Full text
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer
John D. Norris, Stephanie J. Ellison, Jennifer G. Baker et al. · Journal of Clinical Investigation · 2017 · 59 citations · Full text
<i>PIK3CA</i> mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation
Grace R. Anderson, Suzanne E. Wardell, Lorin Crawford et al. · Science Translational Medicine · 2016 · 58 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 9